PolyPid Ltd
PYPD
$2.93
Closing
▼-2.01%
1D
▼-22.89%
YTD
PYPD
BBG002Q6KV48
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$20.07M
Analysts' Rating
BUY
Price Target (Mean)
12.33
Total Analysts
3
P/E
Operating Margin
0.00%
Beta
1.38
Revenue Growth
0.00%
52 week high
$9.20
52 week low
$2.90
Div. Yield
%
EPS Growth
-8.76
Company Profile
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
